Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KLAC vs GSK✓SelectedUSD · GSKKLAC vs GSK performance historyLatest closeAs of-5.35%11/16
Stock and ETF performance explorer

KLAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+122,153.5%
GSK return
+1,741.1%
Excess return
+120,412.4%
Maximum drawdown
-83.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.3%-0.1%-5.3%-5.3%
7D-4.8%-1.3%-3.4%-4.3%
30D-13.0%+2.7%-15.7%-14.2%
3M-29.1%+2.7%-31.9%-30.6%
6M-19.9%+3.3%-23.2%-22.4%
YTD+19.1%+6.5%+12.6%+13.3%
1Y+27.8%+10.7%+17.1%+19.5%
3Y+170.0%+64.4%+105.6%+108.0%
5Y+256.7%+46.7%+210.1%+182.7%
10Y+2,058.0%+109.4%+1,948.7%+1,378.4%
All+122,153.5%+1,741.1%+120,412.4%+42,357.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling